{
  "hits": 206,
  "size": 50,
  "data": [
    {
      "title": "三季报点评：短期增速略有下滑，看好长期发展空间",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000187",
      "orgName": "万联证券股份有限公司",
      "orgSName": "万联证券",
      "publishDate": "2018-11-02 00:00:00.000",
      "infoCode": "AP201811021231873517",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9200000000",
      "predictLastYearPe": "44.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000251335.姚文"
      ],
      "indvIsNew": "001",
      "researcher": "姚文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 458,
      "attachPages": 5,
      "encodeUrl": "ZKpkq3XA83ggxJhJ7OCySPzuifEpX9fvqUTWZAbjGUQ=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000251335"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "三季报点评：Q3单季业绩略有波动，全年高增长趋势不变",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-11-02 00:00:00.000",
      "infoCode": "AP201811021231159586",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "45.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000245127.缪牧一"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,缪牧一",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 284,
      "attachPages": 7,
      "encodeUrl": "ZKpkq3XA83ggxJhJ7OCySM9Luee6NwbwEIlxF7CwC/M=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000210529",
        "11000245127"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "三季报跟踪：Q3增速放缓，无碍长期发展前景",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2018-10-30 00:00:00.000",
      "infoCode": "AP201810301224742524",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9000000000",
      "predictLastYearPe": "46.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000173527.李平祝",
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "李平祝,王晓琦",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 593,
      "attachPages": 10,
      "encodeUrl": "3ZlPIxOmaTLQ2lAnrvuLjGU9bGahGqVW7k0Zzm6bIHI=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000173527",
        "11000277542"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "费用影响Q3业绩增速，全年业绩有望持续保持高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-10-29 00:00:00.000",
      "infoCode": "AP201810291223889672",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9000000000",
      "predictLastYearPe": "46.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000278731.方驭涛"
      ],
      "indvIsNew": "001",
      "researcher": "方驭涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 609,
      "attachPages": 4,
      "encodeUrl": "p3w2w4LU4CM/WOkZ+0MWFaqalDO+D/rBkgdMX3ufXVA=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000278731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩基本符合预期，全年高增长有望延续",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-10-29 00:00:00.000",
      "infoCode": "AP201810291223449946",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9000000000",
      "predictLastYearPe": "46.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 655,
      "attachPages": 4,
      "encodeUrl": "p3w2w4LU4CM/WOkZ+0MWFUiRIYV1SncWO2yewng5kCU=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年第三季度报告点评：基本符合预期，投资收益或持续增厚业绩",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-10-28 00:00:00.000",
      "infoCode": "AP201810271223364145",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9400000000",
      "predictLastYearPe": "44.0900000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 390,
      "attachPages": 3,
      "encodeUrl": "XGbzbWwhjY+3YZZL8rkxv59TRPfLpZblczN8m7evMvU=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "半年报深度跟踪：业绩保持高速增长，未来高成长性确定",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2018-09-17 00:00:00.000",
      "infoCode": "AP201809171196628804",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.2300000000",
      "predictLastYearPe": "39.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000173527.李平祝",
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "李平祝,王晓琦",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 706,
      "attachPages": 19,
      "encodeUrl": "t5juac3a/Wnqc8ZU3/BvD9uw6jbM/woLNxio94ST0VE=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000173527",
        "11000277542"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "中报点评：营业收入持续快速增长，长期看好",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000197",
      "orgName": "中航证券",
      "orgSName": "中航证券",
      "publishDate": "2018-09-04 00:00:00.000",
      "infoCode": "AP201809041187728416",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8900000000",
      "predictLastYearPe": "62.4500000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 526,
      "attachPages": 3,
      "encodeUrl": "ZNhqLi9dlEnDvI7DjUUuyprDhu04XMEvaL7WqkRpnRk=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000177532"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018半年报点评：业绩稳步增长，看好临床CRO业务未来发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000187",
      "orgName": "万联证券股份有限公司",
      "orgSName": "万联证券",
      "publishDate": "2018-09-03 00:00:00.000",
      "infoCode": "AP201809031186912716",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9000000000",
      "predictLastYearPe": "60.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000222033.宋江波",
        "11000251335.姚文"
      ],
      "indvIsNew": "001",
      "researcher": "宋江波,姚文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 273,
      "attachPages": 3,
      "encodeUrl": "LtfiahmDBg8cwNV5i0qeT5VELNPeEWuH2kKHXSiBrWk=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000222033",
        "11000251335"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年中报点评：业绩略超预期，2018赛季佳绩可期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-08-29 00:00:00.000",
      "infoCode": "AP201808291184544990",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9500000000",
      "predictLastYearPe": "59.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000245127.缪牧一"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,缪牧一",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 705,
      "attachPages": 7,
      "encodeUrl": "ttgIfk2IOFMmCIvemKTrIzNIM+S4HNfiAoU6P12hB1Q=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000210529",
        "11000245127"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩高速增长，同步推出股权激励计划",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-08-29 00:00:00.000",
      "infoCode": "AP201808291184528003",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "59.6000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000278731.方驭涛"
      ],
      "indvIsNew": "001",
      "researcher": "方驭涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 643,
      "attachPages": 4,
      "encodeUrl": "ttgIfk2IOFMmCIvemKTrIx1kB2LRzDCegi/4VyEdjr8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000278731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年半年度报告点评：扣非业绩超预期，环比提升73.74%",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-08-28 00:00:00.000",
      "infoCode": "AP201808281184052547",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0200000000",
      "predictLastYearPe": "56.5400000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 341,
      "attachPages": 3,
      "encodeUrl": "6TCvFnXzCm6uuLfHt460wwoZ/B0fApiSgSmjjz+WoLg=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "【联讯医药公司中报点评】泰格医药：政策护航，业绩飞奔",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000118",
      "orgName": "联讯证券股份有限公司",
      "orgSName": "联讯证券",
      "publishDate": "2018-08-28 00:00:00.000",
      "infoCode": "AP201808281183824720",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "62.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000240732.李志新"
      ],
      "indvIsNew": "001",
      "researcher": "李志新",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 864,
      "attachPages": 6,
      "encodeUrl": "6TCvFnXzCm6uuLfHt460w63B/7rQVBKjMXm4wjjkwv4=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000240732"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，期权激励保障快速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-08-28 00:00:00.000",
      "infoCode": "AP201808281183803113",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9200000000",
      "predictLastYearPe": "62.7700000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 777,
      "attachPages": 4,
      "encodeUrl": "6TCvFnXzCm6uuLfHt460w1Oe/izQ+A+t6Clsz0w44Ao=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩略超预期，主营增长稳健，投资收益贡献业绩弹性",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-07-02 00:00:00.000",
      "infoCode": "AP201807021161629749",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "66.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 611,
      "attachPages": 4,
      "encodeUrl": "R22Sr0Ki/nH3MGsuk68KW9OIqK78UcV4BN6ZjtOpIq4=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年半年度业绩预告点评：内生持续高增长，汇兑损益或缩窄",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-07-02 00:00:00.000",
      "infoCode": "AP201807021161563272",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9200000000",
      "predictLastYearPe": "67.2500000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 305,
      "attachPages": 3,
      "encodeUrl": "R22Sr0Ki/nH3MGsuk68KW309X0QKZMbCDHSJcgSF1HY=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "一季度主营高增长，投资收益稳定可持续",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-04-26 00:00:00.000",
      "infoCode": "AP201804261130988870",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "62.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 611,
      "attachPages": 4,
      "encodeUrl": "6IaZ/rjIoVhLQaOznBxTzQTzCswMGMGPhQliWgkOLGU=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "临床核查影响基本消除，BE业务快速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000187",
      "orgName": "万联证券股份有限公司",
      "orgSName": "万联证券",
      "publishDate": "2018-04-26 00:00:00.000",
      "infoCode": "AP201804261130707847",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8300000000",
      "predictLastYearPe": "66.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000222032.沈赟",
        "11000251335.姚文"
      ],
      "indvIsNew": "001",
      "researcher": "沈赟,姚文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 300,
      "attachPages": 3,
      "encodeUrl": "6IaZ/rjIoVhLQaOznBxTzWuuit5mUGQww3VsGf6p260=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000222032",
        "11000251335"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩如期高增长，持续受益于鼓励创新与一致性评价推进",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-04-20 00:00:00.000",
      "infoCode": "AP201804201127322801",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9300000000",
      "predictLastYearPe": "61.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 612,
      "attachPages": 4,
      "encodeUrl": "H1ESWQ2ZxoNwbAk8N57ZD9ZjQa+zDIv250ye9lyArOE=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "年报点评：业绩符合预期，临床CRO龙头腾飞在即",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2018-04-20 00:00:00.000",
      "infoCode": "AP201804201127021534",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9000000000",
      "predictLastYearPe": "63.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210529.张金洋",
        "11000245127.缪牧一"
      ],
      "indvIsNew": "001",
      "researcher": "张金洋,缪牧一",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 394,
      "attachPages": 9,
      "encodeUrl": "H1ESWQ2ZxoNwbAk8N57ZD5wtpeBWOkQboIFgl3DXAC8=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000210529",
        "11000245127"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "BE试验+创新药临床，公司业绩持续高速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2018-04-20 00:00:00.000",
      "infoCode": "AP201804201127013768",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8400000000",
      "predictLastYearPe": "67.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 655,
      "attachPages": 4,
      "encodeUrl": "H1ESWQ2ZxoNwbAk8N57ZDw85F9vw1HclZca5VDJAP+A=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017年年报点评：行业高景气，业绩有望持续改善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-04-20 00:00:00.000",
      "infoCode": "AP201804201126785282",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9200000000",
      "predictLastYearPe": "61.5100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 296,
      "attachPages": 3,
      "encodeUrl": "H1ESWQ2ZxoNwbAk8N57ZDxtfLDplKNj/y5LfERQyHxA=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "需求强劲，定价能力增强；上调目标价至人民币62.1元",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80056613",
      "orgName": "北京高华证券有限责任公司",
      "orgSName": "高华证券",
      "publishDate": "2018-04-18 00:00:00.000",
      "infoCode": "AP201804181125558976",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8200000000",
      "predictLastYearPe": "62.6000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000245836.陈子易"
      ],
      "indvIsNew": "001",
      "researcher": "陈子易",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "62.1000000000",
      "indvAimPriceL": "62.1000000000",
      "attachType": "0",
      "attachSize": 364,
      "attachPages": 5,
      "encodeUrl": "EId67V7e0Lh+Bcb+rGV1nojWj+5igcFGHsMUBx4XtKY=",
      "sRatingName": "买入",
      "sRatingCode": "0103",
      "market": "SHENZHEN",
      "authorID": [
        "11000245836"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2018年第一季度业绩预告点评：内生高增长，投资收益确认加快",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-04-07 00:00:00.000",
      "infoCode": "AP201804051118243084",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8800000000",
      "predictLastYearPe": "57.8400000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000239134.宋红欣",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "宋红欣,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 313,
      "attachPages": 3,
      "encodeUrl": "EcknUDW5iqE+bIxNsHIDwTnQCYqONGsiIIWjX2QR9fA=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000239134",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩快报点评：收入逐季提速，业绩快速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2018-03-07 00:00:00.000",
      "infoCode": "AP201803071100165838",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7870000000",
      "predictLastYearPe": "48.2700000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000177532.沈文文",
        "11000197438.石玉华"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文,石玉华",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 491,
      "attachPages": 3,
      "encodeUrl": "D2kl2YjPI3ETuttv0W31E0RZ+JypbKsLPv9dkZlqEmA=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000177532",
        "11000197438"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩如预期恢复，长期将受益于创新药CRO需求提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2018-02-28 00:00:00.000",
      "infoCode": "AP201802281095415706",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8200000000",
      "predictLastYearPe": "46.2400000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "42.2000000000",
      "indvAimPriceL": "42.2000000000",
      "attachType": "0",
      "attachSize": 282,
      "attachPages": 3,
      "encodeUrl": "RRm+Mvg0bGPNFBikr1DV1jZI86EJhS75k/uS3SVeEfM=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，大临床与BE业务持续高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2018-02-27 00:00:00.000",
      "infoCode": "AP201802271094973635",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8100000000",
      "predictLastYearPe": "47.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 608,
      "attachPages": 4,
      "encodeUrl": "7FW8rVZHtTmZPK/DNGRarWbRHXOv+xCEx83/sWgyFQI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "【联讯医药公司点评】泰格医药：年报业绩符合预期，鼓励创新药和仿制药一致性评价政策双受益",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000118",
      "orgName": "联讯证券股份有限公司",
      "orgSName": "联讯证券",
      "publishDate": "2018-02-27 00:00:00.000",
      "infoCode": "AP201802271094948050",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7800000000",
      "predictLastYearPe": "48.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000176281.王凤华",
        "11000240732.李志新"
      ],
      "indvIsNew": "001",
      "researcher": "王凤华,李志新",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "43.1000000000",
      "indvAimPriceL": "43.1000000000",
      "attachType": "0",
      "attachSize": 891,
      "attachPages": 6,
      "encodeUrl": "7FW8rVZHtTmZPK/DNGRarepfJxPUcA9gT3JqTgnZxGE=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000176281",
        "11000240732"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017年业绩快报点评：2017业绩高增长，长期坚定看好",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2018-02-26 00:00:00.000",
      "infoCode": "AP201802261094723743",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8000000000",
      "predictLastYearPe": "47.5100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000239134.宋红欣",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "宋红欣,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 399,
      "attachPages": 3,
      "encodeUrl": "QuBuaQKODiwl7qtpdtq/YhafUqX0xrcm3RpVNw8t+rA=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000239134",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩基本符合预期，主营持续高增长，投资收益增加业绩弹性",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-12-26 00:00:00.000",
      "infoCode": "AP201712261069721776",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8100000000",
      "predictLastYearPe": "42.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 607,
      "attachPages": 4,
      "encodeUrl": "V6l5epnFNcWrtM7cI+CF/KWybSsJEKu5hpeOw/zkkvI=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "短期业绩恢复，BE带来弹性，长期将受益于创新药CRO需求提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2017-12-25 00:00:00.000",
      "infoCode": "AP201712251069680767",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8100000000",
      "predictLastYearPe": "41.5700000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "38.0000000000",
      "indvAimPriceL": "38.0000000000",
      "attachType": "0",
      "attachSize": 222,
      "attachPages": 3,
      "encodeUrl": "3qiF2dvorHqUsW4syoJXZqtZ0hDbwPsJfuDIMQzV9Z8=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "公告点评：布局欧洲，国际化进一步推进",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2017-12-18 00:00:00.000",
      "infoCode": "AP201712181067531632",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7800000000",
      "predictLastYearPe": "41.3500000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 527,
      "attachPages": 3,
      "encodeUrl": "I3qbEbRU65d8yK7HCsYXUbEwPn9Cx6I1QwvkPlRLRAU=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "行业景气度提升，产业链布局完善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2017-12-14 00:00:00.000",
      "infoCode": "AP201712141066297745",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.78",
      "predictLastYearPe": "40.83",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1092,
      "attachPages": 26,
      "encodeUrl": "D4avVdSs/Mwoj4K7NYu5EaGooBqlvzXw6Eeja9b1Hfg=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "BE业务快速增长，三季度业绩提升明显",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2017-11-20 00:00:00.000",
      "infoCode": "AP201711201052546231",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7600000000",
      "predictLastYearPe": "42.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000249332.肖汉山",
        "11000239345.蔡明子"
      ],
      "indvIsNew": "001",
      "researcher": "肖汉山,蔡明子",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 587,
      "attachPages": 5,
      "encodeUrl": "N83YIwo2IjfVfu0uTjGJfw7hawkaBhvyRHNQyTMgIoY=",
      "sRatingName": "谨慎推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000249332",
        "11000239345"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017前三季度业绩同比增长101%，业绩继续恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2017-11-03 00:00:00.000",
      "infoCode": "AP201711031002801799",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7600000000",
      "predictLastYearPe": "42.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "36.0000000000",
      "indvAimPriceL": "36.0000000000",
      "attachType": "0",
      "attachSize": 226,
      "attachPages": 3,
      "encodeUrl": "yiwNB4wujxFIGMPhwWGPhyOPwkeN+D3LHNd98j3GKEI=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "三季度业绩增速明显加快，毛利率大幅回升，全年高增长获确认",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-10-30 00:00:00.000",
      "infoCode": "AP201710300990574899",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7500000000",
      "predictLastYearPe": "42.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 608,
      "attachPages": 4,
      "encodeUrl": "U9X2kZCO9DYdImnYn0BDiAHdrGZCSFiX6UiL3ZcIi9M=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "【联讯医药季报点评】泰格医药：业绩逐季走高，政策助力公司业绩高增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000118",
      "orgName": "联讯证券股份有限公司",
      "orgSName": "联讯证券",
      "publishDate": "2017-10-30 00:00:00.000",
      "infoCode": "AP201710300990464760",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7700000000",
      "predictLastYearPe": "41.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000176281.王凤华",
        "11000240732.李志新"
      ],
      "indvIsNew": "001",
      "researcher": "王凤华,李志新",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "43.1000000000",
      "indvAimPriceL": "43.1000000000",
      "attachType": "0",
      "attachSize": 950,
      "attachPages": 6,
      "encodeUrl": "U9X2kZCO9DYdImnYn0BDiODpaVmeIVWf3bir0NuEEZk=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000176281",
        "11000240732"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017年三季报点评：Q3业绩略超预期，逐季改善明显",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2017-10-30 00:00:00.000",
      "infoCode": "AP201710300990450523",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7800000000",
      "predictLastYearPe": "40.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 527,
      "attachPages": 3,
      "encodeUrl": "U9X2kZCO9DYdImnYn0BDiGipsinc5AbC34+nb3Jp0Ps=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，公司毛利率逐季恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-10-30 00:00:00.000",
      "infoCode": "AP201710300990337854",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8600000000",
      "predictLastYearPe": "37.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 761,
      "attachPages": 4,
      "encodeUrl": "U9X2kZCO9DYdImnYn0BDiCWQSfWbVh1YNZ/a5VFEAbk=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017年三季报预告点评：Q3略超预期，政策助业绩再提速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2017-10-12 00:00:00.000",
      "infoCode": "AP201710110945817857",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.78",
      "predictLastYearPe": "40",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 528,
      "attachPages": 3,
      "encodeUrl": "+4sDAuCbFEEre52BSV9DSAF8qB4XZpkgfNSHezpyeKI=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "投资医院扩产能，承接订单能力增强",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2017-10-08 00:00:00.000",
      "infoCode": "AP201710080938712942",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7600000000",
      "predictLastYearPe": "37.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000249332.肖汉山",
        "11000239345.蔡明子"
      ],
      "indvIsNew": "001",
      "researcher": "肖汉山,蔡明子",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 742,
      "attachPages": 5,
      "encodeUrl": "XN+ifwbBv5NPuzIcjGaDDFzAIMdDScA1J84UGKTe6nE=",
      "sRatingName": "谨慎推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000249332",
        "11000239345"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "CRO龙头，BE业务贡献业绩增量",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2017-09-04 00:00:00.000",
      "infoCode": "AP201709040854693480",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1100000000",
      "predictLastYearPe": "24.7600000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000257837.杨欧雯",
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "杨欧雯,周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1530,
      "attachPages": 34,
      "encodeUrl": "+BOeUdApURr13FOBkdwUD4OjoJcBBK6EuiNV/pv60j8=",
      "sRatingName": "增持",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000257837",
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017H1业绩同比增长53%，业绩恢复明显",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2017-08-23 00:00:00.000",
      "infoCode": "AP201708230822893264",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7600000000",
      "predictLastYearPe": "32.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "30.4000000000",
      "indvAimPriceL": "30.4000000000",
      "attachType": "0",
      "attachSize": 220,
      "attachPages": 3,
      "encodeUrl": "co7Ebh4mwQp/KiZbP3XRXOgQ1o78MXGYsY4ZeLRns+g=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "确认重返高增长，看好BE业务带来的业绩增量",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券股份有限公司",
      "orgSName": "华安证券",
      "publishDate": "2017-08-23 00:00:00.000",
      "infoCode": "AP201708230822766865",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7500000000",
      "predictLastYearPe": "36.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 569,
      "attachPages": 4,
      "encodeUrl": "co7Ebh4mwQp/KiZbP3XRXHlwCT2qA7KT7DU6jmbJVMs=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩略超预期，各项业务全面向好，高增长可期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-08-23 00:00:00.000",
      "infoCode": "AP201708230821905906",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8900000000",
      "predictLastYearPe": "30.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林",
        "11000258552.张肖星"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林,张肖星",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "33.0000000000",
      "indvAimPriceL": "33.0000000000",
      "attachType": "0",
      "attachSize": 730,
      "attachPages": 4,
      "encodeUrl": "co7Ebh4mwQp/KiZbP3XRXJWdnAtZhmU5dJMdY7lUx+g=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544",
        "11000258552"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2017H1业绩同比上升40%-60%，业绩继续恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券",
      "orgSName": "群益证券",
      "publishDate": "2017-07-04 00:00:00.000",
      "infoCode": "AP201707040691571681",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7600000000",
      "predictLastYearPe": "32.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "30.4000000000",
      "indvAimPriceL": "30.4000000000",
      "attachType": "0",
      "attachSize": 218,
      "attachPages": 3,
      "encodeUrl": "mto56l45TNlrafhFrVtK62ZrKwhoVV9at7VYHyaiHzI=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩略超预期，公司逐季向好",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2017-07-04 00:00:00.000",
      "infoCode": "AP201707040690414425",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8900000000",
      "predictLastYearPe": "27.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "33.0000000000",
      "indvAimPriceL": "33.0000000000",
      "attachType": "0",
      "attachSize": 768,
      "attachPages": 4,
      "encodeUrl": "mto56l45TNlrafhFrVtK64EW7cMRgyiVmzaQRITExcE=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000250544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩恢复高增长，中报略超预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000064",
      "orgName": "华安证券",
      "orgSName": "华安证券",
      "publishDate": "2017-07-03 00:00:00.000",
      "infoCode": "AP201707030688390872",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.7500000000",
      "predictLastYearPe": "31.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000250641.医药生物行业组"
      ],
      "indvIsNew": "001",
      "researcher": "医药生物行业组",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 572,
      "attachPages": 4,
      "encodeUrl": "qJmw66P4vZiFblPd18LlBdRtiboBfmBdPyDDT6zwvTc=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000250641"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "【联讯医药公司点评】泰格医药：中报大幅预增，业绩增速加快，拐点更清晰",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000118",
      "orgName": "联讯证券股份有限公司",
      "orgSName": "联讯证券",
      "publishDate": "2017-07-03 00:00:00.000",
      "infoCode": "AP201707030688284541",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.8000000000",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "医药制造",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000176281.王凤华",
        "11000240732.李志新"
      ],
      "indvIsNew": "001",
      "researcher": "王凤华,李志新",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "33.0000000000",
      "indvAimPriceL": "33.0000000000",
      "attachType": "0",
      "attachSize": 836,
      "attachPages": 6,
      "encodeUrl": "qJmw66P4vZiFblPd18LlBVgY+tFadAY2DP5lVegVjP4=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000176281",
        "11000240732"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "【联讯医药深度研究报告】泰格医药：CRO产业链上下垂直一体化，业绩反转“知更鸟”立上枝头",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000118",
      "orgName": "联讯证券股份有限公司",
      "orgSName": "粤开证券",
      "publishDate": "2017-06-30 00:00:00.000",
      "infoCode": "AP201706300680162653",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.0700000000",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "465",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000176281.王凤华",
        "11000240732.李志新"
      ],
      "indvIsNew": "001",
      "researcher": "王凤华,李志新",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "33.0000000000",
      "indvAimPriceL": "33.0000000000",
      "attachType": "0",
      "attachSize": 2377,
      "attachPages": 27,
      "encodeUrl": "w4xWF+GGUfaLJ/NwCdkYY+NuUfoSMPrxbKgXu6jwYcc=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000176281",
        "11000240732"
      ],
      "count": 0,
      "orgType": "white"
    }
  ],
  "TotalPage": 5,
  "pageNo": 4,
  "currentYear": 2025
}